Medicine Man Technologies Inc.

Medicine Man Technologies Inc.

OOTC:SHWZ
0.00
USD
0.00
(0.00%)
-0.43EPS
Nov 18Next Earn

Important Dates

Medicine Man Technologies Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

Earnings Date11/18/2026

Share Statistics

As of December 31, 2023, Medicine Man Technologies Inc. has 74.05M shares outstanding.

Shares Outstanding74.05M

Financial Position

As of December 31, 2023, Medicine Man Technologies Inc. maintains a current ratio of 0.97, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 160.84, indicating elevated leverage, while an interest coverage ratio of 0.76 demonstrates limited ability to service its debt obligations.

Current Ratio0.97
Quick Ratio0.43
Debt / Equity160.84
Debt / EBITDA7.92
Interest Coverage0.76

Financial Efficiency

USD

Over the twelve months ended December 31, 2023, Medicine Man Technologies Inc. posted a negative return on equity (ROE) of -33.97, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -10.15, reflecting losses generated across the asset base. The company generates approximately 232,958.85 in revenue per employee across its workforce of 740.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.99 indicates how many times Medicine Man Technologies Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-33.97
Return on Assets (ROA)-10.15
Revenue Per Employee232,958.85
Employee Count740.25
Inventory Turnover3.99

Taxes

USD

Over the twelve months ended December 31, 2023, Medicine Man Technologies Inc. recorded 19.74M in income tax expense. The company reported a pretax loss of -14.81M and -34.55M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax19.74M

Stock Price Statistics

USD

As of the close on November 2, 2026, Medicine Man Technologies Inc.'s stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

200-Day Moving Average0.01

Income Statement

USD

Over the twelve months ended December 31, 2023, Medicine Man Technologies Inc. generated 172.45M in revenue and converted that into -34.55M in net income, yielding earnings per share of -0.43. EBITDA reached 24.22M, while operating income came in at 5.09M.

Revenue172.45M
Gross Profit76.02M
Operating Income5.09M
Pretax Income-14.81M
Net Income-34.55M
EBITDA24.22M
EBIT3.29M
Earnings Per Share (EPS)-0.43

Balance Sheet

USD

As of December 31, 2023, Medicine Man Technologies Inc. holds 19.71M in cash and equivalents against 191.87M in total debt, resulting in a net debt position of 137.56M. Total book value stands at 119.29M, with working capital of -1.79M providing operational flexibility.

Cash & Cash Equivalents19.71M
Total Debt191.87M
Net Debt137.56M
Equity (Book Value)119.29M
Book Value Per Share1.61
Working Capital-1.79M

Cash Flow

USD

Medicine Man Technologies Inc. produced 12.20M in operating cash flow over the twelve months ended December 31, 2023. After subtracting -10.62M in capital expenditures, free cash flow totaled 1.59M - equivalent to 0.02 per share.

Operating Cash Flow12.20M
Capital Expenditures-10.62M
Free Cash Flow1.59M
FCF Per Share0.02

Margins

Over the twelve months ended December 31, 2023, Medicine Man Technologies Inc. posted a gross margin of 44.08, reflecting its pricing power and cost economics. The operating margin of 2.95 and net profit margin of -20.03 provide insight into operational efficiency.

Gross Margin44.08
Operating Margin2.95
Pretax Margin-8.59
Profit Margin-20.03
EBITDA Margin14.05

Dividends & Yields

These figures cover the twelve months ended December 31, 2023. The dividend payout ratio of 19.10 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Payout Ratio19.10